AGP Executive Report

Last update: 6 hours ago

Nuclear Energy: Hyundai E&C has signed a design contract with Westinghouse for two proposed Dutch reactors, covering site reviews, project planning and local licensing requirements. Dutch Tech Deals: New York-based Zeta Global is buying Amsterdam’s Digital Audience, whose data and AI tools connect customer insights to marketing channels. Self-Driving Scrutiny: Dutch approval of Tesla’s driver-assistance system has helped open the path to an EU-wide decision, but safety researchers dispute the company’s crash-reduction claims. Digital Security: Dutch researchers say thousands of European wind and solar systems are exposed online, highlighting risks to clean-energy infrastructure. Materials Innovation: Delft-developed self-healing concrete, which uses bacteria to seal small cracks, is heading to a major U.S. industry showcase.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 6, 2026

NPS uses JIFX to fast-track defense tech from drones to energy systems

AGP

fallback image
Oct. 3, 2026

Maureen B. Roberts launches cosmic science fantasy epic and 2027 companion book

AGP

fallback image
Oct. 1, 2026

EU accessibility fines remain rare as Dutch checkout failures mount

AGP

fallback image
Sep. 30, 2026

Nebi to sponsor CCW Europe Summit 2026 in Amsterdam

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Press Release Service Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Press Release Service
Indeterminate

fallback image
Oct. 7, 2026

Circle8 Netherlands Secures $314 Million Four-Year Contract With DUO Groningen

GlobeNewswire, Inc.

fallback image
Oct. 7, 2026

Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

Circle8 Netherlands Signs $492 Million Four-Year Contract Across Three Dutch Government Bodies

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

Energizing the Technology of Tomorrow

EIN Presswire

fallback image
6 hours ago

argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease

GlobeNewswire, Inc.

fallback image
Oct. 5, 2026

Aravax to Communicate Results of its Phase 2 Clinical Trial of PVX108, a Novel immunotherapy for the Treatment of Peanut Allergy, at Major Scientific Meetings in November 2026

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Willem de Kooning Returns to the Netherlands for Major Rijksmuseum Exhibition
Play
Willem de Kooning Returns to the Netherlands for Major Rijksmuseum Exhibition
YouTube video thumbnail: German Ex-Spy Chief Arrested for Suspected Espionage, Treason
Play
German Ex-Spy Chief Arrested for Suspected Espionage, Treason
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: French Students: What Do They Want?
Play
French Students: What Do They Want?
YouTube video thumbnail: Russia Plague Fears After Death of Lab Worker at Research Centre
Play
Russia Plague Fears After Death of Lab Worker at Research Centre

Video Title

Sign up for:

Technology Presswire Netherlands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Presswire Netherlands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.